Slide Library

Help your patients understand Obesity is a disease and it needs to be treated. Obesity is quickly becoming an epidemic in the United States.

Key Points

• Obesity is a chronic relapsing progressive disease defined by abnormal or excessive adiposity that may impair health.
• Improved ability to engage in activities of daily living such as improved mo

Key Points

• Obesity has a genetic basis as well as environmental and behavioral origins
• Age contributes to a shift in balance between fat and muscle mass
• Various negative feedback loops contribu

Key Points

• Four weight-loss surgical options are available
  • Laparoscopic adjustable gastric band (LAGB)
  • Laparscopic sleeve gastrectomy (LSG)
  • Biliopancreatic diversion with or witho

Key Points

• Evaluation of patients for obesity should include a complete history and physical examination
• Body mass index (BMI) cutpoints vary with race and ethnicity
• Waist circumference

Key Points

• Clinical evaluation of obese patients should include a complete history and physical examination
• Comorbidities and obesity complications should also be assessed
• Treatment plans shoul

Key Points

• Obesity is increasing globally
  • Rates of obesity have risen dramatically in the U.S.

Key Points

• Obesity is associated with higher risks of prediabetes and type 2 diabetes (T2D)
• Weight loss with lifestyle therapy, pharmacotherapy, or bariatric surgery
  • Reduces the risk of progr

Key Points

• Obesity is associated with increased cardiovascular risk
• Weight loss by means of lifestyle therapy, pharmacotherapy, or bariatric surgery positively affects cardiovascular risk markers

Key Points

• Numerous organ-specific and biomechanical complications accompany obesity
• Weight loss ameliorates all of these conditions

Key Points

• Depression, anxiety, eating disorders, and other psychological conditions frequently are associated with obesity
• Weight loss may positively affect the psychological complications of obesity.

Key Points

• Lifestyle interventions effectively prevent physical and metabolic complications of obesity
  • Lifestyle alone is less effective in populations with more severe obesity

Key Points

• Weight-loss medications should be considered when obesity-related complications can be ameliorated by weight loss.
• Pharmacotherapy should always be combined with lifestyle therapy, never used

Key Points

• Older obesity pharmacotherapies are limited by tolerability and dependence issues and are approved only for short-term use (≤12 weeks).
• Newer weight loss agents are typically better tolerated,